TACR1 and acute myeloid leukemia: In AML patients, an increased microvessel density has been reported in bone marrow, meaning that, in this disease, angiogenesis plays an important role and hence an anti-angiogenic strategy (using NK-1R antagonists) could be beneficial for the treatment of AML (Figure 1) [18,19,75].